PMID: 8463442Apr 1, 1993Paper

Open prospective trial of fluoxetine for posttraumatic stress disorder

Journal of Clinical Psychopharmacology
L M NagyD S Charney

Abstract

Twenty-seven patients with combat-related posttraumatic stress disorder (PTSD) entered an open, prospective, 10-week trial of fluoxetine, beginning with 20 mg/day and increasing to 80 mg/day until response was optimal or side effects prohibited dose increase. Nineteen patients completed 3 or more weeks and were included in the data analysis. Total Clinician-Administered PTSD Scale scores decreased from a mean of 64.5 at baseline to 42.7 at endpoint (F = 7.17, p < 0.001), and improvement was significant in each of the three PTSD subscales (reexperiencing, avoidance/numbing, and hyperarousal). Depression and anxiety ratings showed similar improvements, and suicidality ratings did not increase. Global improvement scores decreased from 4.0 at baseline to 2.67 at endpoint (F = 12.08, p < 0.001); however, improvement in social and occupational functioning was minimal. Appreciable improvement tended to occur after 6 weeks, suggesting that higher fluoxetine doses and/or duration than that used for depression may be indicated in this population. Panic attack frequency decreased by at least 50% in six of eight patients who kept panic diaries. The high dropout rate reflects problems with side effects, anxiety symptoms, external events, an...Continue Reading

Citations

Jan 1, 1995·Journal of Traumatic Stress·D D BlakeT M Keane
Sep 15, 1995·Biological Psychiatry·C A MorganD S Charney
Dec 23, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Wissam El HageCatherine Belzung
Jan 1, 2003·Current Therapeutic Research, Clinical and Experimental·Joseph F GoldbergHyemee Han
Oct 24, 2002·Journal of Psychiatric Research·Ronald C Albucher, Israel Liberzon
Apr 11, 2003·Child Abuse & Neglect·David C WrightErin R Kraftcheck
May 5, 2001·Pharmacology & Therapeutics·S V ArgyropoulosD J Nutt
Feb 2, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Stewart D BarnettJonathan R T Davidson
Oct 16, 1999·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·M Isaac
Sep 1, 1994·Journal of the American Academy of Child and Adolescent Psychiatry·B BirmaherM Brodsky
Aug 22, 2008·Croatian Medical Journal·Dragica Kozaric-Kovacic
Aug 28, 2001·Neuropharmacology·C BelzungG Griebel
Aug 5, 2008·Burns : Journal of the International Society for Burn Injuries·Rhonda RobertWalter J Meyer
Mar 1, 1994·General Hospital Psychiatry·M B Hamner
Dec 17, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Ferenc Martenyi, Victoria Soldatenkova
Apr 1, 1997·The Australian and New Zealand Journal of Psychiatry·R D AlarconH C Eddleman
Jan 27, 2006·The Cochrane Database of Systematic Reviews·D J SteinS Seedat
Dec 16, 1998·The British Journal of Psychiatry : the Journal of Mental Science·P D LondborgC Weise
Sep 15, 2020·Health Technology Assessment : HTA·Hollie MeltonPeter Coventry
Aug 5, 2000·The Annals of Pharmacotherapy·M Cyr, M K Farrar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Related Papers

The British Journal of Psychiatry : the Journal of Mental Science
K M ConnorJ R Davidson
Psychotherapy and Psychosomatics
M De BoerH Van Duijn
© 2021 Meta ULC. All rights reserved